NCT04883476

Brief Summary

This prospective observation multifaceted study aims:

  1. 1.To perform a large prospective study and identify multiple "omics" biomarkers in chronic low back pain
  2. 2.To validate identified biomarkers for progression of acute to chronic low back pain
  3. 3.To validate identified biomarkers and test their heritability/validity in additional cohorts
  4. 4.To identify pathways and relevant individual variations for generation, propagation and subsidence of pain
  5. 5.To identify new imaging biomarkers related to chronic low back pain
  6. 6.To develop a registry of neck and low back pain subjects to help monitor the health-care management and utility to improve protocols and patient outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
6 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 12, 2021

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

10.2 years

First QC Date

April 26, 2021

Last Update Submit

April 27, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Radiographic assessment

    assess the subjects' standing X-ray of the whole spine (AP and lateral) for the presence and extent of atherosclerosis, endplate thickening (sclerosis), vertebral osteophytes, limbus vertebrae, presence and categorization of vertebral subluxation (spondylolisthesis), additional spine-related deformities, spinal canal and vertebral body/foraminal dimensions, and static/dynamic spinal motion parameters and alignments. This will be done at interval follow-ups

    Change up to 60-months follow-up

  • MRI assessment

    MRI: Sagittal T2W MRI whole spine and axial T1W MRI of lumbar spine will be assessed in all subjects. The radiographic events/outcomes of interest entailed the presence and extent of disc degeneration, disc bulges/herniations, Schmorl's nodes (endplate irregularities), high-intensity zones (HIZ), and bone marrow signal changes involving the endplate. Interval assessments will be made.

    Change up to 60-months follow-up

Secondary Outcomes (9)

  • Oswestry Disability index

    Change to 60-months follow-up

  • Neck disability index

    Change to 60-months follow-up

  • Neck pain disability scale

    Change to 60-months follow-up

  • Depression-Anxiety Stress Scale

    Change to 60-months follow-up

  • SF-36

    Change to 60-months follow-up

  • +4 more secondary outcomes

Study Arms (1)

Chronic Low Back Pain and Neck Pain

Other: Observation study only

Interventions

Chronic Low Back Pain and Neck Pain

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients were referred to the specialist orthopaedic clinic

You may qualify if:

  • Neck and/or low back pain
  • New cases\*
  • Males and females
  • years or older
  • Willing to participate in the study short- and long-term

You may not qualify if:

  • Previous spine surgery
  • Cognitively impaired
  • Drug addiction
  • Incarceration (prisoner)
  • History of infections, tumors, chronic inflammation (e.g. rheumatoid arthritis, ankylosing spondylitis)
  • Congenital/syndromal
  • Pregnant females
  • Diagnosed psychological impairment
  • Inability to read or write

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Mary Hospital

Hong Kong, Hong Kong

Location

Biospecimen

Retention: SAMPLES WITH DNA

Tests for low density lipoprotein (LDL), high density lipoprotein (HDL), cholesterol counts, triglycerides, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), metabolomics, glycomics, CCL5/CCL6 and adipokines.

Study Officials

  • Dr. Jason Cheung

    The University of Hong Kong/ Queen Mary Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

April 26, 2021

First Posted

May 12, 2021

Study Start

May 1, 2015

Primary Completion

June 30, 2025

Study Completion

December 31, 2025

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations